ML15267A825

Shine SER References

ML15267A825
Person / Time
Site:	SHINE Medical Technologies
Issue date:	10/08/2015
From:	Office of Nuclear Reactor Regulation
To:
Lynch S
Shared Package
ML15267A796	List: ML15267A802 ML15267A812 ML15267A813 ML15267A814 ML15267A815 ML15267A816 ML15267A817 ML15267A818 ML15267A819 ML15267A820 ML15267A822 ML15267A824 ML15267A825 ML15267A826 ML15267A827 ML15267A828
References
Download: ML15267A825 (6)

Text

Appendix B: References 1. Letter SMT-2013-Medical Technologies, Inc. Application for Construction Permit, May 31, 2013, Agencywide Documents Access and Management System (ADAMS) Accession No. ML13172A361). 2. Letter SMT-2013-012 Medical Technologies, Inc. Application for Construction Permit, dated March 26, 2013, ADAMS Accession No. ML13088A192. 3. Letter SMT-2013-033, Medical Technologies, Inc. Preliminary Emergency Plan, dated September 25, 2013, ADAMS Accession No. ML13269A378. 4. NUREG-idelines for Preparing and Reviewing Applications for the Licensing of Non-Accession No. ML042430055. 5. NUREG-Licensing of Non-February 1996, ADAMS Accession No. ML042430048. 6. -Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format 17, 2012, ADAMS Accession No. ML12156A069. 7. -r Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: October 17, 2012, ADAMS Accession No. ML12156A075. 8. Letter from U.S. Nuclear Regulatory Commission (S. Lynch), to SHINE Medical 2.101(a)(5), Regarding the Submission of a Construction Permit Application in Two ADAMS Accession No. ML13072B195. 9. Letter SMT-2013-010 18, 2013, ADAMS Accession No. ML13051A007. 10. Letter from U.S. Nuclear Regulatory Commission (S. Lynch), to SHINE Medical ADAMS Accession No. ML13150A280. 11. Letter from U.S. Nuclear Regulatory Commission (S. Lynch), to SHINE Medical ADAMS Accession No. ML13233A356. 12. Letter from U.S. Nuclear Regulatory Commission (S. Lynch), to SHINE Medical ML13316B387. 13. reliminary Safety Analysis Report2015, ADAMS Package Accession No. ML15175A274. 14. Letter from U.S. Nuclear Regulatory Commission (A. Adams), to SHINE Medical Application for ConsML14195A159. 15. Letter from U.S. Nuclear Regulatory Commission (D. Hardesty for A. Adams), to SHINE Adated January 6, 2015, ADAMS Accession No. ML15005A407. 16. Letter from U.S. Nuclear Regulatory Commission (A. Adams), to SHINE Medical ML15055A116. 17. Letter from U.S. Nuclear Regulatory Commission (S. Lynch), to SHINE Medical April 15, 2015, ADAMS Accession No. ML15099A607. 18. Letter from U.S. Nuclear Regulatory Commission (A. Adams), to SHINE Medical dated September XX, 2015 MLXXXXXXXXX. 19. ble in ADAMS, Accession No. ML15175A274 20. Letter SMT-2014-2014, ADAMS Package Accession No. ML14296A189. 21. Letter SMT-2014-040 from Construction December 3, 2014, ADAMS Package Accession No. ML14356A527. 22. Letter SMT-2015-004 from 2015, ADAMS Package Accession No. ML15043A404. 23. Letter SMT-2015-cation for Construction Permit, Response to Request for Additional Information 11.1-March 23, 2015, ADAMS Package Accession No. ML15092A397. 24. Letter SMT-2015-Construction Permit, Response to Request for Additional Information2015, ADAMS Package Accession No. ML15120A248. 25. Letter SMT-2015-Construction Permit, Response to Request for Additional Infor2015, ADAMS Package Accession No. ML15131A464. 26. Letter SMT-2015-2015, ADAMS Package Accession No. ML15147A211. 27. Letter SMT-2015-Construction Permit, Response to Request for Additional Information 13a2.2-5May 20, 2015, ADAMS Package Accession No. ML15140A734. 28. Letter SMT-2015-2015, ADAMS Package Accession No. ML15183A292. 29. Letter SMT-2015-036 from SHINE Medical TConstruction Permit, Response to Request for Additional Information 6b.3-30June 19, 2015, ADAMS Package Accession No. ML15222A231. 30. Letter SMT-2015-0XX or 2015, ADAMS Package Accession No. MLXXXXXXXX. 31. Letter SMT-2013-Construction Permit, Response to Envirdated October 4, 2013, ADAMS Accession No. ML13303A887. 32. Proceedings of the Workshop on Subcritical Reactivity Measurements, 1985. 33. Nuclear Waste Policy Act of 1982, Public Law No.97-425, 96 Stat. 2201, January 7, 1983. 34. NFPA 13, 2013 Edition, Quincy, MA. 35. SHINE Medical Technologies v. 0 - Chapter 03 - Figures 3.4-001 through 3.4-014, ADAMS Accession No. ML13172A291. 36. Table 8a2.1-,ADAMS Accession No. ML13172A270, page 8a2-6. 37 U.S. Nuclear Regulatory Commission May 2009, ADAMS Accession No. ML090820425. 38. U 39. Fuel 19, September 9, 2005, ADAMS Accession Number No. ML052520232. 40. U.S. Department of EnergyAccident Analysis for Aircraft Crash into Hazardous Facilities, DOE-STD-3014-96, October 1996, Reaffirmed May 2006. 41. International IAEA-TECDOC-1347, March 2003. 42. U.S. Nuclear Regulatory Commission, Regulatory Guide 1.78, Revision 1, the Habitability of a Nuclear Power Plant Control Room During a Postulated Hazardous December 2001, ADAMS Accession No. ML013100014. 43. National Oceanic and Atmospheric Administration, ALOHA (Areal Locations of Hazardous Atmospheres), Version 5.4.4, Technical Documentation, Technical Memorandum NOS OR&R 43, November 2013. 44. -7004, NUREG-1851, September 2006. 45. SHINE Medical Technologies v. 0 - Chapter 02 - Figures 2.4-001 through 2.4-011, SHINE PSAR Figure 2.4-4, Measured Groundwater Elevations in Monitoring Wells, ADAMS Accession No. ML13172A288. 46. published in 1982, is website (http://wgnhs.uwex.edu/pubs/download_m078paper/). 47. SHINE Medical Technologies v. 0 - Chapter 08 - Figure 8a2.2-001, SHINE PSAR, --Line Diagram Uninterruptible Electrical Power Supply System,No. ML13172A298. 48. U.S. Guidelines for Evaluating Electromagnetic and Radio-Frequency Interference in Safety Related , Revision 1, October 2003, ADAMS Accession No ML032740277. 49. National Fire Protection Association (NFPA) 70- 50. IEEE Std. 384- 51. - 52. NUREG-, ADAMS Accession No. ML062190191. 53. U.S. Nuclear Regulatory Commission, , ADAMS Accession No. ML003740234. 54. ANSI/ANS-15.16-September 23, 2008. 55. ANSI/ANS 15.1- 56. U.S. Nuclear Regulatory Commission, Content for a Licensee Physical Security Plan for the Protection of Special Nuclear February 1983, ADAMS Accession No. ML003739253. 57. ANSI/ANS-15.8-Reactors. 58. U.S. Nuclear Regulatory Commission, , ML101650030. 59. U.S. Nuclear Regulatory Commission, NUREG-2183, DRFC Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility Draft Report fADAMS Accession No. ML15127A241. 60. U.S. Nuclear Regulatory Commission, NUREG-1520, Revision 1, Plan for the Review of a , ADAMS Accession No. ML101390110. 61. SHINE Medical Technologies v. 0 - Chapter 13 Accident Analysis,Accession No. ML14356A465. 62. ANSI/ANS-8.1-1998 Fissionable Materials Outside Reactors,La Grange Park, Illinois, U.S.A. 63. ANSI/ANS-8.3-an Nuclear Society, La Grange Park, Illinois, U.S.A. 64. ANSI/ANS-8.7- 65. ANSI/ANS-8.10-1983 Grange Park, Illinois, U.S.A. 66. ANSI/ANS-8.20-American Nuclear Society, La Grange Park, Illinois, U.S.A. 67. ANSI/ANS-8.21- 68. ANSI/ANS-8.23-American Nuclear Society, La Grange Park, Illinois, U.S.A. 69. ANSI/ANS-8.24-Nuclear Criticality Safety Calculations,Illinois, U.S.A. 70. ANSI/ANS-8.26-,American Nuclear Society, La Grange Park, Illinois, U.S.A. 71. IEEE Std 379--Failure Criterion to Electronics Engineers, Piscataway, NJ, 2000. 72. U.S. Nuclear Regulatory Commission, Regulatory Guide 1-ADAMS Accession No. ML033220006. 73. -Service Testing of Nuclear Air Treatment, Heating, 74. ASME AG 75. U.S. Nuclear Regulatory Commission, Nuclear , ADAMS Accession No. ML103210345. 76. ANSI/ANS-8.19-Nuclear Society, La Grange Park, Illinois, U.S.A. 77. Nuclear Regulatory Commission, NUREG/CR-6698Guide for Validation of Nuclear Criticality Safety Calculational Methodology January 2001 ADAMS Accession No. ML050250061. 78. -0612, July 1980, ADAMS Accession No. ML070250180.